StockData
BioAtla, Inc. logo

BioAtla, Inc. (BCAB) stock

BCABOTCBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 4/30
$1.31−0.05 (-3.68%)

Close on Oct 19, 2026Market cap $2.18MP/E –Yield –

BioAtla revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

BioAtla's revenue for the twelve months ending Sep 30, 2022 was $0. For fiscal 2021 it was $300.00K.

Annual revenue

PeriodPeriod endValueChange
FY2021Dec 31, 2021$300.00K–

Quarterly revenue

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2023Sep 30, 2023$0–
Q2 FY2023Jun 30, 2023$0–
Q1 FY2023Mar 31, 2023$0–
Q3 FY2022Sep 30, 2022$0–
Q2 FY2022Jun 30, 2022$0-100.0%
Q1 FY2022Mar 31, 2022$0–
Q4 FY2021Dec 31, 2021$0–
Q3 FY2021Sep 30, 2021$0–
Q2 FY2021Jun 30, 2021$300.00K–

More BioAtla figures

See a number that looks wrong?